Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 17.20
-0.10 (-0.58%)
Oct 9, 2025, 2:59 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 10.00 billion as of October 10, 2025. Its market cap has decreased by -25.87% in one year.
Market Cap
10.00B
Enterprise Value
5.16B
Revenue
301.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
17.20
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 10.00B, a decrease of -56.38%. That is a compound annual growth rate of -31.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 10.00B | 0.24% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 198.23B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |